113¦~¤K¤ë¸¹ ¹D ªk ªk °T (388) |
DEEP & FAR |
|
³Ì°ªªk°|±À½¤FIPHC¤j¦Xij®x¡]Grand Panel¡^ªº§P¨M¡A¨Ã ©Ó»{¡u¤èªk¬É©w²£ª«¡v¤§½Ð¨D¶µÀ³²[»\»P¤èªkµLÃöªº¬Û¦P²£ «~¡A¦ý¡K Teva Gyogyszergyar Zartkoruen Mukodo Rt. (±M§QÅv¤H) v. Kyowa Hakko Kirin Co., Ltd. (³Q«ü±±«IÅv¤H)¡A®×¥ó½s¸¹2012 (Jyu) 1204 (2015¦~6¤ë5¤é§@¥Xªº§P¨M) |
¶À§ÀR ±M§Q¤uµ{®v ¡E¶§©ú¤j¾Çª«²zªvÀø¨t ¡E¶§©ú¤j¾Ç¥Íª«ÃÄ¾Ç©Ò |
|
|
||
³Ì°ªªk°|±À½¤F´¼¼z°]²£°ªµ¥ªk°|¡]IPHC¡^¤j¦Xij®x1)©ó2012¦~§@¥XªºÃö©ó«Øºc¡u¤èªk¬É©w²£ª«¡v½Ð¨D¶µ2)½d³òªº§P¨M¡A¨Ãµô©w¡u¤èªk¬É©w²£ª«¡v½Ð¨D¶µªº½d³òÀ³³Q½T©w¬°¨ã¦³»PÂǥѽШD¶µ¤¤©w¸qªº¤èªk©Ò¥Í²£ªº²£«~¬Û¦Pªºµ²ºc¡B©Ê½èµ¥ªº²£«~¡A§Y¨Ï¦b½Ð¨D¶µ¤¤©w¸q¤F¥Í²£¸Ó²£«~ªº¤èªk¡C¤]´N¬O»¡¡A³Ì°ªªk°|©Ó»{¡u¤èªk¬É©w²£ª«¡v½Ð¨D¶µ²[»\©Ò¦³»PÂǥѽШD¶µ¤¤©w¸qªº¤èªk©Ò¥Í²£ªº²£«~¬Û¦Pªºµ²ºc©Î©Ê½èªº²£«~¡A§Y¨Ï¥Î©ó¥Í²£¸Ó²£«~ªº¹ê»Ú¤èªk»P½Ð¨D¶µ¤¤ªº¤èªk¤£¦P¡C
µM¦Ó¡A³Ì°ªªk°|¶i¤@¨Bµô©w¡A¦b¡u¤èªk¬É©w²£ª«¡v½Ð¨D¶µªº±¡ªp¤U¡A¥u¦³¦b¦³²z¥Ñ¨Ï±o¦b¥Ó½Ð±M§Q¥Ó½Ð®×®É¤£¥i¯à©Î§¹¥þ¤£¤Á¹ê»Ú¦aÂǥѩҽв£«~ªºµ²ºc©Î©Ê½èª½±µ©w¸q¸Ó²£«~®É¡A¤~º¡¨¬¡]±M§Qªk²Ä36±ø²Ä¡]6¡^´Ú²Ä¡]ii¡^¶µ³W©wªº¡^©ú½T©Ên¨D¡C
µù¡G
1)
¥l¶}¤j¦Xij®x¼f²z»Ýn¹ê½è¤W²Î¤@ªk°|§P¨Mªº®×¥ó¡A©ÎªÌ¯A¤Î«¤j°ÝÃDªº®×¥ó¡A¦³ÂIÃþ¦ü©ó¬ü°êCAFCªº¥þÅéªk©x·|ij(en
banc session)¡C
2)
¡u¤èªk¬É©w²£ª«¡v½Ð¨D¶µ¬O¤@ºØ²£«~½Ð¨D¶µ¡A¨ä¤¤©w¸q¤F²£«~ªº»s³Æ¹Lµ{¡C